BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27403431)

  • 1. Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.
    Lin S; Yin YA; Jiang X; Sahni N; Yi S
    Biomed Res Int; 2016; 2016():6186281. PubMed ID: 27403431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing genomic alterations in cancer by complementary functional associations.
    Kim JW; Botvinnik OB; Abudayyeh O; Birger C; Rosenbluh J; Shrestha Y; Abazeed ME; Hammerman PS; DiCara D; Konieczkowski DJ; Johannessen CM; Liberzon A; Alizad-Rahvar AR; Alexe G; Aguirre A; Ghandi M; Greulich H; Vazquez F; Weir BA; Van Allen EM; Tsherniak A; Shao DD; Zack TI; Noble M; Getz G; Beroukhim R; Garraway LA; Ardakani M; Romualdi C; Sales G; Barbie DA; Boehm JS; Hahn WC; Mesirov JP; Tamayo P
    Nat Biotechnol; 2016 May; 34(5):539-46. PubMed ID: 27088724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating cancer genomes sequencing revolution into surgical oncology practice.
    Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
    J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity.
    Tan H; Bao J; Zhou X
    Sci Rep; 2015 Jul; 5():12566. PubMed ID: 26212640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of networks of co-occurring, tumor-related DNA copy number changes using a genome-wide scoring approach.
    Klijn C; Bot J; Adams DJ; Reinders M; Wessels L; Jonkers J
    PLoS Comput Biol; 2010 Jan; 6(1):e1000631. PubMed ID: 20052266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.
    Ruffalo M; Koyutürk M; Sharan R
    PLoS Comput Biol; 2015 Dec; 11(12):e1004595. PubMed ID: 26683094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of algorithms for the detection of cancer drivers at subgene resolution.
    Porta-Pardo E; Kamburov A; Tamborero D; Pons T; Grases D; Valencia A; Lopez-Bigas N; Getz G; Godzik A
    Nat Methods; 2017 Aug; 14(8):782-788. PubMed ID: 28714987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
    Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
    Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next steps in next-gen sequencing of cancer genomes.
    Hayes DN; Kim WY
    J Clin Invest; 2015 Feb; 125(2):462-8. PubMed ID: 25642706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in 2011: Genomics in hepatocellular carcinoma--a big step forward.
    Tateishi R; Omata M
    Nat Rev Gastroenterol Hepatol; 2012 Jan; 9(2):69-70. PubMed ID: 22230901
    [No Abstract]   [Full Text] [Related]  

  • 14. Next-Generation Sequencing.
    Le Gallo M; Lozy F; Bell DW
    Adv Exp Med Biol; 2017; 943():119-148. PubMed ID: 27910067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in Next-Generation Sequencing.
    Levy SE; Myers RM
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():95-115. PubMed ID: 27362342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Big science: The cancer genome challenge.
    Ledford H
    Nature; 2010 Apr; 464(7291):972-4. PubMed ID: 20393534
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.
    Shah RH; Scott SN; Brannon AR; Levine DA; Lin O; Berger MF
    Cancer Cytopathol; 2015 May; 123(5):289-97. PubMed ID: 25655233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
    Titeux M; Izmiryan A; Hovnanian A
    J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.